Vanta in ₹29-cr deal with Emcure

Our Bureau Hyderabad | Updated on April 08, 2019

Vanta Bioscience Limited has announced that its step-down subsidiary ‘Vayam Research Solutions Limited’ has entered into a non-exclusive CRO Service Agreement with Emcure Pharmaceuticals Limited, Pune, for providing services of bio-analytical and bio-equivalence services to the company for a period of three years from 2019 to 2022. In a listing to the bourses today, the company said the agreement provides for a minimum revenue assurance between ₹7 crore and ₹9 crore for the financial year 2019-20 and ₹20 crore for fiscal 2020-21.

Published on April 08, 2019

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor